---
$id: https://graph.org.ai/products/commodity/51283004
$type: Product
source: UNSPSC
code: "51283004"
title: "Clindamycin palmitate"
class: "51283000"
classTitle: "Lincosamides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clindamycin palmitate

**UNSPSC Code**: 51283004
**Class**: [Lincosamides](Lincosamides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a lincosamide antibiotic with the molecular formula C34H63ClN2O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C501Z28AFG, chemically known as methyl (2s-trans)-7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-l-threo-alpha-d-galacto-octopyranoside, monopalmitate (ester) but more generally known as clindamycin palmitate, which bears US NIH Compound Identifier 83855. Most nations, for tariff and trade purposes, schedule clindamycin palmitate under HS 29419000 and SITC 54139. As of Q4 2014, CLINDAMYCIN PALMITATE remains US FDA's Preferred Term for this commodity. SMILES: CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@H]([C@H](O[C@@H]1SC)[C@@H]([C@H](C)CL)NC(=O)[C@@H]2C[C@H](CN2C)CCC)O)O.

